North American Crotalidae Venom Proteins (NACVP)

This target refers to the complex mixture of toxic proteins and peptides found in the venom of four major North American pit viper species: Crotalus atrox, Crotalus adamanteus, Crotalus scutulatus, and Agkistrodon piscivorus (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550197/). These venoms contain a diverse array of enzymes and non-enzymatic proteins, including snake venom metalloproteinases (SVMPs), snake venom serine proteases (SVSPs), phospholipases A2 (PLA2s), and disintegrins (https://pubmed.ncbi.nlm.nih.gov/11101237/). Biologically, these components act synergistically to immobilize and digest prey by inducing systemic effects such as coagulopathy, hemorrhage, and neurotoxicity, as well as local effects like severe tissue necrosis and edema (https://www.ncbi.nlm.nih.gov/books/NBK431065/). In a clinical context, these proteins are the primary targets for polyvalent antivenoms like CroFab, which utilize purified Fab fragments to bind and neutralize the toxins (https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103911s5181lbl.pdf). The antivenom works by sequestering the toxins in the vascular space, preventing them from reaching their physiological targets and facilitating their elimination. Effective management of envenomation requires rapid administration of these antivenoms to prevent permanent tissue damage or death. Monitoring of coagulation parameters and platelet counts is essential to assess the efficacy of the neutralization in patients.

Other names

Crotalid venom antigensPit viper venom toxinsCrotalus and Agkistrodon venom componentsNorth American pit viper venom

The drugs consist of venom-specific antibody fragments (Fab or F(ab')2) that bind to and neutralize the circulating venom toxins, preventing them from interacting with their physiological targets and facilitating their redistribution and elimination.